BriaCell Therapeutics Corp. (BCTX)
NASDAQ: BCTX · Real-Time Price · USD
4.180
0.00 (0.00%)
At close: May 1, 2026, 4:00 PM EDT
4.160
-0.020 (-0.48%)
After-hours: May 1, 2026, 7:43 PM EDT
BriaCell Therapeutics Employees
BriaCell Therapeutics had 16 employees as of July 31, 2023. The number of employees increased by 10 or 166.67% compared to the previous year.
Employees
16
Change
10
Growth
166.67%
Revenue / Employee
n/a
Profits / Employee
-$1,852,354
Market Cap
30.29M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Jul 31, 2023 | 16 | 10 | 166.67% | 16 | 0 |
| Jul 31, 2021 | 6 | 0 | - | 5 | 1 |
| Aug 1, 2019 | 6 | - | - | 5 | 1 |
Related Stocks
| Company Name | Employees |
|---|---|
| Senti Biosciences Holdings | 34 |
| Kyntra Bio | 34 |
| Lisata Therapeutics | 21 |
| NeuroSense Therapeutics | 17 |
| Quantum BioPharma | 17 |
| Tvardi Therapeutics | 12 |
| Skye Bioscience | 12 |
| Rein Therapeutics | 10 |
BCTX News
- 5 days ago - BriaCell Announces Six Clinical Data Presentations at ASCO 2026 - GlobeNewsWire
- 11 days ago - BriaCell (BCTX) Showcases Promising Data at AACR Annual Meeting - GuruFocus
- 11 days ago - BriaCell Presents Robust Anti-Cancer Activity of Bria-OTS+™ in Preclinical Cancer Models - GlobeNewsWire
- 12 days ago - BriaCell (BCTX) Showcases Positive Clinical Data at AACR Annual Meeting - GuruFocus
- 12 days ago - BriaCell Presents Positive Phase 3 Quality of Life and Phase 2 Biomarker Data at the 2026 AACR Meeting - GlobeNewsWire
- 4 weeks ago - BriaCell and BriaPro Announce Closing of Asset Purchase Transaction for Exclusive Soluble CD80 License - GlobeNewsWire
- 6 weeks ago - BriaCell (BCTX) to Reveal Key Findings at 2026 AACR Annual Meeting - GuruFocus
- 6 weeks ago - BriaCell to Present Positive Clinical Data for Bria-IMT™ and Preclinical Data for Next Generation Bria-OTS+™ Personalized Immunotherapy at the 2026 AACR Conference - GlobeNewsWire